State of the Union: Transcatheter Tricuspid Valve Interventions
Presenter
David J. Cohen, M.D., FSCAI, St. Francis Hospital, New York, NY
David J. Cohen, M.D., FSCAI, St. Francis Hospital, New York, NY
Learning Objectives:
- Review 2025 developments: Efficacy data from Evoque and TriClip approvals, showing 80-90% TR reduction and quality-of-life improvements in high-risk patients.
- Analyze imaging and device selection advancements, including CT-guided annuloplasty and leaflet modification to mitigate right ventricular strain.
- Glimpse into the future: Orthotopic replacements, bicaval implants like TricValve, and trials exploring early intervention in secondary TR to prevent heart failure progression.